Abstract:Microvascular destabilization is the primary cause of the inner blood-retinal barrier (iBRB) breakdown and increased vascular leakage in diabetic retinopathy (DR). Microvascular destabilization results from the combinational effects of increased levels of growth factors and cytokines, involvement of inflammation, and the changed cell-to-cell interactions, especially the loss of endothelial cells and pericytes, due to hyperglycemia and hypoxia. As the manifestation of microvascular destabilization, the fluid transports via paracellular and transcellular routes increase due to the disruption of endothelial intercellular junctional complexes and/or the altered caveolar transcellular transport across the retinal vascular endothelium. With diabetes progression, the functional and the structural changes of the iBRB components, including the cellular and noncellular components, further facilitate and aggravate microvascular destabilization, resulting in macular edema, the neuroretinal damage and the dysfunction of retinal inner neurovascular unit (iNVU). Although there have been considerable recent advances towards a better understanding of the complex cellular and molecular network underlying the microvascular destabilization, some still remain to be fully elucidated. Recent data indicate that targeting the intricate signaling pathways may allow to against the microvascular destabilization. Therefore, efforts have been made to better clarify the cellular and molecular mechanisms that are involved in the microvascular destabilization in DR. In this review, we discuss: (1) the brief introduction of DR and microvascular destabilization; (2) the cellular and molecular components of iBRB and iNVU, and the breakdown of iBRB; (3) the matrix and cell-to-cell contacts to maintain microvascular stabilization, including the endothelial glycocalyx, basement membrane, and various cell-cell interactions; (4) the molecular mechanisms mediated cell-cell contacts and vascular cell death; (5) the altered cytokines and signaling pathways as well as the intricate network of the cytokines involved in microvascular destabilization. This comprehensive review aimed to provide the insights for microvascular destabilization by targeting the key molecules or specific iBRB cells, thus restoring the function and structure of iBRB and iNVU, to treat DR.

Protective factors in diabetic retinopathy: focus on blood-retinal barrier.

Role of Pericytes in Mechanisms of Diabetic Retinopathy

Inflammatory Machenism in the Pathogenesis of Diabetic Retinopathy

The pathophysiological mechanisms underlying diabetic retinopathy

Diabetic retinopathy: Involved cells, biomarkers, and treatments

An overview of the pathogenesis of diabetic retinopathy

Diabetic Retinopathy: Pathophysiology and Treatments

Molecules related to diabetic retinopathy in the vitreous and involved pathways

Diabetic Macular Edema: Current Understanding, Molecular Mechanisms and Therapeutic Implications

Retinal Cell Damage in Diabetic Retinopathy

Effects of systemic risk factors on the development of diabetic retinopathy

Recent advances in the treatment and delivery system of diabetic retinopathy

Molecular Mechanisms of Diabetic Retinopathy, General Preventive Strategies, and Novel Therapeutic Targets

Involvement of Advanced Glycation End Products in the Pathogenesis of Diabetic Retinopathy

Glucose transport, transporters and metabolism in diabetic retinopathy

External Limiting Membrane, Photoreceptor Ellipsoid Zone Disruption, and Retinal Pigment Epithelium Alterations in Diabetic Retinopathy

Oxidative Stress-Related Mechanisms and Antioxidant Therapy in Diabetic Retinopathy

Microvascular destabilization and intricated network of the cytokines in diabetic retinopathy: from the perspective of cellular and molecular components

Prevention and treatment of diabetic retinopathy: progress, challenges and future prospects

Diabetic retinopathy: current understanding, mechanisms, and treatment strategies